Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial

Anchalee Avihingsanon, Hongzhou Lu, Chee Loon Leong, Chien‐Ching Hung, Ellen Koenig, Sasisopin Kiertiburanakul, Man‐Po Lee, Khuanchai Supparatpinyo, Fujie Zhang, Sophia Rahman, Michelle L. D’Antoni, Hongyuan Wang, Jason T. Hindman, Hal Martin, Jared M. Baeten, Taisheng Li